<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9164841" created="13/11/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9164841</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Involvement of the <term id="A4" sem="Protein_domain_or_region"><term id="T1" lex="N-terminal_region" sem="Protein_domain_or_region">N-terminal region</term> of the <term id="T2" lex="human_mineralocorticoid_receptor_hormone-binding_domain" sem="Protein_domain_or_region">human <term id="A3" sem="Protein_family_or_group">mineralocorticoid receptor</term> hormone-binding domain</term></term> in <term id="A1" sem="Organic_compound_other">agonist</term> and <term id="A2" sem="Organic_compound_other">antagonist</term> binding as revealed by a <term id="T3" lex="new_monoclonal_antibody" sem="Protein_family_or_group">new monoclonal antibody</term>.</sentence>
<event KT="Other" id="E1">
<type class="Binding"/>
<theme idref="A1"/>
<theme idref="A3"/>
<clue>Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist <clueType>binding</clueType> as revealed by a new monoclonal antibody.</clue>
<comment>NO COREFETHEME FOR A3</comment></event>
<event KT="Other" id="E2">
<type class="Binding"/>
<theme idref="A2"/>
<theme idref="A3"/>
<clue>Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist <clueType>binding</clueType> as revealed by a new monoclonal antibody.</clue>
<comment>NO COREFETHEME FOR A3</comment></event>
<event KT="Analysis" id="E3">
<type class="Correlation"/>
<theme idref="A4"/>
<theme idref="E1"/>
<clue><clueType>Involvement</clueType> <linkTheme>of</linkTheme> the N-terminal region of the human mineralocorticoid receptor hormone-binding domain <linkTheme>in</linkTheme> agonist and antagonist binding as <clueKT>revealed</clueKT> by a new monoclonal antibody.</clue>
<comment>TPS A4</comment></event>
<event KT="Analysis" id="E4">
<type class="Correlation"/>
<theme idref="A4"/>
<theme idref="E2"/>
<clue><clueType>Involvement</clueType> <linkTheme>of</linkTheme> the N-terminal region of the human mineralocorticoid receptor hormone-binding domain <linkTheme>in</linkTheme> agonist and antagonist binding as <clueKT>revealed</clueKT> by a new monoclonal antibody.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">To gain a better understanding of the mechanism of binding to the <term id="T4" lex="human_mineralocorticoid_receptor" sem="Protein_family_or_group">human mineralocorticoid receptor</term> (<term id="T5" lex="hMR" sem="Protein_family_or_group">hMR</term>), we developed a new <term id="T6" lex="monoclonal_antibody" sem="Protein_family_or_group">monoclonal antibody</term> (<term id="T7" lex="mAb" sem="Protein_family_or_group">mAb</term>) raised against the <term id="T8" lex="hormone-binding_domain" sem="Protein_domain_or_region">hormone-binding domain</term> (<term id="T9" lex="HBD" sem="Protein_domain_or_region">HBD</term>).</sentence>
<event KT="Investigation" id="E5">
<type class="Binding"/>
<theme idref="T5"/>
<clue><clueKT>To gain a better understanding</clueKT> of the mechanism of <clueType>binding</clueType> <linkTheme>to</linkTheme> the human mineralocorticoid receptor (hMR), we developed a new monoclonal antibody (mAb) raised against the hormone-binding domain (HBD).</clue>
</event>
<sentence id="S3">For this purpose, <term id="T10" lex="mouse" sem="Multicellular_organism_natural">mice</term> were immunized with a <term id="T11" lex="fusion_protein" sem="Protein_complex">fusion protein</term> including the sequence <term id="T12" lex="Thr729-Lys984" sem="Protein_domain_or_region">Thr729-Lys984</term> of <term id="T13" lex="hMR" sem="Protein_family_or_group">hMR</term>.</sentence>
<sentence id="S4">After <term id="T14" lex="ELISA_screening" sem="Other">ELISA screening</term>, <term id="T15" lex="mAb_18C7" sem="Protein_molecule">mAb 18C7</term> was selected for its specificity towards the <term id="T16" lex="HBD" sem="Protein_domain_or_region">HBD</term>.</sentence>
<sentence id="S5">This antibody recognized both the <term id="A5" sem="Protein_family_or_group">denatured</term> and <term id="A6" sem="Protein_family_or_group">native</term> <term id="T17" lex="native_MR_form" sem="Protein_family_or_group">MR forms</term>, as well as the <term id="T18" lex="hetero-oligomeric_MR_form" sem="Protein_molecule">hetero-oligomeric MR form</term> and the <term id="T19" lex="transformed_MR_state" sem="Protein_molecule">transformed <term id="A50" sem="Protein_family_or_group">MR</term> state</term>.</sentence>
<event id="E7">
<type class="Binding"/>
<theme idref="T15"/>
<theme idref="A5" idref1="T17"/>
<clue><corefTheme>This antibody</corefTheme> <clueType>recognized</clueType> both the denatured and native MR forms, as well as the hetero-oligomeric MR form and the transformed MR state.</clue>
<comment>NER T17 MOD</comment></event>
<event id="E8">
<type class="Binding"/>
<theme idref="T15"/>
<theme idref="A6" idref1="T17"/>
<clue><corefTheme>This antibody</corefTheme> <clueType>recognized</clueType> both the denatured and native MR forms, as well as the hetero-oligomeric MR form and the transformed MR state.</clue>
</event>
<event id="E9">
<type class="Binding"/>
<theme idref="T15"/>
<theme idref="T18"/>
<clue><corefTheme>This antibody</corefTheme> <clueType>recognized</clueType> both the denatured and native MR forms, <linkTheme>as well as</linkTheme> the hetero-oligomeric MR form and the transformed MR state.</clue>
</event>
<event id="E10">
<type class="Binding"/>
<theme idref="T15"/>
<theme idref="T19"/>
<clue><corefTheme>This antibody</corefTheme> <clueType>recognized</clueType> both the denatured and native MR forms, <linkTheme>as well as</linkTheme> the hetero-oligomeric MR form and the transformed MR state.</clue>
</event>
<event Polarity="Negative" id="E110">
<type class="Protein_metabolism"/>
<theme idref="T17"/>
<clue>This antibody recognized both the <clueType><cluePolarity>denatured</cluePolarity></clueType> and native MR forms, as well as the hetero-oligomeric MR form and the transformed MR state.</clue>
</event>
<event id="E210">
<type class="Protein_metabolism"/>
<theme idref="A50"/>
<clue>This antibody recognized both the denatured and native MR forms, as well as the hetero-oligomeric MR form and the <clueType>transformed</clueType> MR state.</clue>
</event>
<sentence id="S6">By using several <term id="T20" lex="HBD_subfragment" sem="Protein_molecule">HBD subfragments</term>, the <term id="T21" lex="mAb_18C7_epitope" sem="Protein_domain_or_region"><term id="T22" lex="mAb_18C7" sem="Protein_molecule">mAb 18C7</term> epitope</term> was located in the <term id="T23" lex="N-terminal_region" sem="Protein_domain_or_region">N-terminal region</term> of the <term id="T24" lex="HBD" sem="Protein_domain_or_region">HBD</term> from <term id="T25" lex="Thr729_to_Leu765" sem="Protein_domain_or_region">Thr729 to Leu765</term>.</sentence>
<sentence id="S7">We then studied the effect of the antibody on <term id="T26" lex="aldosterone" sem="Lipid">aldosterone</term> and <term id="T27" lex="progesterone" sem="Lipid">progesterone</term> binding to the <term id="T28" lex="hMR" sem="Protein_family_or_group">hMR</term>.</sentence>
<event KT="Other" id="E12">
<type class="Binding"/>
<theme idref="T26"/>
<theme idref="T28"/>
<clue>We then studied the effect of the antibody on aldosterone and progesterone <clueType>binding</clueType> <linkTheme>to</linkTheme> the hMR.</clue>
</event>
<event KT="Other" id="E13">
<type class="Binding"/>
<theme idref="T27"/>
<theme idref="T28"/>
<clue>We then studied the effect of the antibody on aldosterone and progesterone <clueType>binding</clueType> <linkTheme>to</linkTheme> the hMR.</clue>
</event>
<event KT="Investigation" id="E14" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E12"/>
<cause idref="T22"/>
<clue>We then <clueKT>studied</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> <corefCause>the antibody</corefCause> <linkTheme>on</linkTheme> aldosterone and progesterone binding to the hMR.</clue>
</event>
<event KT="Investigation" id="E15" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E13"/>
<cause idref="T22"/>
<clue>We then <clueKT>studied</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> <corefCause>the antibody</corefCause> <linkTheme>on</linkTheme> aldosterone and progesterone binding to the hMR.</clue>
</event>
<sentence id="S8">When <term id="T29" lex="18C7" sem="Protein_molecule">18C7</term> was incubated with <term id="T30" lex="liganded_MR" sem="Protein_molecule">liganded <term id="A7" sem="Protein_family_or_group">MR</term></term>, it was able to partly displace (20%) the hormone from its binding site.</sentence>
<event KT="Other" id="E16">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T26"/>
<clue>When 18C7 was incubated with <clueType>liganded</clueType> MR, it was able to partly displace (20%) the hormone from its binding site.</clue>
</event>
<event KT="Other" id="E17">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T27"/>
<clue>When 18C7 was incubated with <clueType>liganded</clueType> MR, it was able to partly displace (20%) the hormone from its binding site.</clue>
</event>
<event KT="Other" id="E18">
<type/>
<theme idref="T26"/>
<theme idref="T24"/>
<clue>When 18C7 was incubated with liganded MR, it was able to partly <clueType>displace</clueType> (20%) <corefTheme idref1="T26">the hormone</corefTheme> <linkTheme>from</linkTheme> <corefTheme idref1="T24">its binding site</corefTheme>.</clue>
<comment>SOO</comment></event>
<event KT="Other" id="E19">
<type/>
<theme idref="T27"/>
<theme idref="T24"/>
<clue>When 18C7 was incubated with liganded MR, it was able to partly <clueType>displace</clueType> (20%) <corefTheme idref1="T27">the hormone</corefTheme> <linkTheme>from</linkTheme> <corefTheme idref1="T24">its binding site</corefTheme>.</clue>
<comment>SOO</comment></event>
<event CL="L2" KT="Analysis" id="E20">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="T29"/>
<clue>When 18C7 was incubated with liganded MR, <corefCause>it</corefCause> was <clueKT><clueCL>able</clueCL></clueKT> to partly displace (20%) the hormone from its binding site.</clue>
</event>
<event CL="L2" KT="Analysis" id="E21">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T29"/>
<clue>When 18C7 was incubated with liganded MR, <corefCause>it</corefCause> was <clueKT><clueCL>able</clueCL></clueKT> to partly displace (20%) the hormone from its binding site.</clue>
</event>
<sentence id="S9">When <term id="T31" lex="18C7" sem="Protein_molecule">18C7</term> was incubated with <term id="T32" lex="MR" sem="Protein_molecule">MR</term> before <term id="T33" lex="aldosterone" sem="Lipid">aldosterone</term> or <term id="T34" lex="progesterone" sem="Lipid">progesterone</term>, the antibody inhibited 75-80% of the binding.</sentence>
<event id="E22">
<type class="Binding"/>
<theme idref="T33"/>
<theme idref="T32"/>
<clue>When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of <corefTheme>the</corefTheme> <clueType>binding</clueType>.</clue>
</event>
<event id="E23">
<type class="Binding"/>
<theme idref="T34"/>
<theme idref="T32"/>
<clue>When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of <corefTheme>the</corefTheme> <clueType>binding</clueType>.</clue>
</event>
<event Manner="High" id="E24">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="T31"/>
<clue>When 18C7 was incubated with MR before aldosterone or progesterone, <corefCause>the antibody</corefCause> <clueType>inhibited</clueType> <clueManner>75-80%</clueManner> of the binding.</clue>
</event>
<event Manner="High" id="E25">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T31"/>
<clue>When 18C7 was incubated with MR before aldosterone or progesterone, <corefCause>the antibody</corefCause> <clueType>inhibited</clueType> <clueManner>75-80%</clueManner> of the binding.</clue>
</event>
<sentence id="S10">The effect of <term id="T35" lex="18C7" sem="Protein_molecule">18C7</term> on the binding was similar with both hormones.</sentence>
<event id="E26">
<type class="Binding"/>
<theme idref="T33"/>
<theme idref="T32"/>
<clue>The effect of 18C7 on the <clueType>binding</clueType> was similar with <corefTheme>both hormones</corefTheme>.</clue>
<comment>NO COREFTEHEME FOR T32</comment></event>
<event id="E27">
<type class="Binding"/>
<theme idref="T34"/>
<theme idref="T32"/>
<clue>The effect of 18C7 on the <clueType>binding</clueType> was similar with <corefTheme>both hormones</corefTheme>.</clue>
<comment>NO COREFTEHEME FOR T32</comment></event>
<event id="E28">
<type class="Regulation"/>
<theme idref="E26"/>
<cause idref="T35"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> 18C7 <linkTheme>on</linkTheme> the binding was similar with both hormones.</clue>
</event>
<event id="E29">
<type class="Regulation"/>
<theme idref="E27"/>
<cause idref="T35"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> 18C7 <linkTheme>on</linkTheme> the binding was similar with both hormones.</clue>
</event>
<sentence id="S11">A sucrose gradient analysis indicated the simultaneous presence of two kinds of receptor complexes: the <term id="T36" lex="steroid-MR_complex" sem="Protein_complex"><term id="A8" sem="Organic_compound_other">steroid</term>-<term id="A9" sem="Protein_family_or_group">MR</term> complex</term> and the <term id="T37" lex="antibody-MR_complex" sem="Protein_complex"><term id="A10" sem="Protein_family_or_group">antibody</term>-<term id="A11" sem="Protein_family_or_group">MR</term> complex</term>.</sentence>
<event CL="L2" KT="Analysis" id="E30">
<type class="Binding"/>
<theme idref="A8"/>
<theme idref="A9"/>
<clue><clueExperiment>A sucrose gradient analysis</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> the simultaneous <clueType>presence</clueType> <linkTheme>of</linkTheme> <corefTheme>two kinds of receptor complexes</corefTheme>: the steroid-MR <clueType>complex</clueType> and the antibody-MR complex.</clue>
</event>
<event CL="L2" KT="Analysis" id="E31">
<type class="Binding"/>
<theme idref="A10"/>
<theme idref="A11"/>
<clue><clueExperiment>A sucrose gradient analysis</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> the simultaneous <clueType>presence</clueType> <linkTheme>of</linkTheme> <corefTheme>two kinds of receptor complexes</corefTheme>: the steroid-MR complex and the antibody-MR <clueType>complex</clueType>.</clue>
</event>
<sentence id="S12">After its associated proteins, especially the <term id="T38" lex="heat-shock_protein_hsp90" sem="Protein_molecule">heat-shock protein hsp90</term>, had been cross-linked with the <term id="T39" lex="hMR" sem="Protein_family_or_group">hMR</term> by <term id="T40" lex="dimethylpimelimidate" sem="Organic_compound_other">dimethylpimelimidate</term>, <term id="T41" lex="18C7" sem="Protein_molecule">18C7</term> was still able to react with the receptor.</sentence>
<event id="E32">
<type class="Binding"/>
<theme idref="T38"/>
<theme idref="T39"/>
<theme idref="T40"/>
<clue>After its associated proteins, especially the heat-shock protein hsp90, had been <clueType>cross-linked</clueType> <linkTheme>with</linkTheme> the hMR <linkTheme>by</linkTheme> dimethylpimelimidate, 18C7 was still able to react with the receptor.</clue>
</event>
<event KT="Other" id="E33">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T41"/>
<clue>After its associated proteins, especially the heat-shock protein hsp90, had been cross-linked with the hMR by dimethylpimelimidate, 18C7 was still able to <clueType>react</clueType> <linkTheme>with</linkTheme> <corefTheme>the receptor</corefTheme>.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E34">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="E32"/>
<clue><linkCause>After</linkCause> its associated proteins, especially the heat-shock protein hsp90, had been cross-linked with the hMR by dimethylpimelimidate, 18C7 was <clueType><cluePolarity>still</cluePolarity> <clueKT><clueCL>able</clueCL></clueKT> to</clueType> <cluePolarity>react</cluePolarity> with the receptor.</clue>
</event>
<sentence id="S13">Our results indicated that the <term id="T42" lex="epitope" sem="Protein_domain_or_region">epitope</term> recognized by <term id="T43" lex="18C7" sem="Protein_molecule">18C7</term> was directly implicated in hormone binding.</sentence>
<event KT="Other" id="E35">
<type class="Binding"/>
<theme idref="T42"/>
<theme idref="T43"/>
<clue>Our results indicated that the epitope <clueType>recognized</clueType> <linkTheme>by</linkTheme> 18C7 was directly implicated in hormone binding.</clue>
</event>
<event KT="Other" id="E36">
<type class="Binding"/>
<theme idref="T32"/>
<theme idref="T33"/>
<clue>Our results indicated that the epitope recognized by 18C7 was directly implicated in <corefTheme>hormone</corefTheme> <clueType>binding</clueType>.</clue>
<comment>NO COREFTEHEME FOR T32</comment></event>
<event KT="Other" id="E37">
<type class="Binding"/>
<theme idref="T32"/>
<theme idref="T34"/>
<clue>Our results indicated that the epitope recognized by 18C7 was directly implicated in <corefTheme>hormone</corefTheme> <clueType>binding</clueType>.</clue>
<comment>NO COREFTEHEME FOR T32</comment></event>
<event CL="L2" KT="Analysis" id="E38">
<type class="Correlation"/>
<theme idref="T42"/>
<theme idref="E36"/>
<clue>Our results <clueCL>indicated</clueCL> that the epitope recognized by 18C7 was directly <clueType><clueKT>implicated</clueKT></clueType> <linkTheme>in</linkTheme> hormone binding.</clue>
</event>
<event CL="L2" KT="Analysis" id="E39">
<type class="Correlation"/>
<theme idref="T42"/>
<theme idref="E37"/>
<clue>Our results <clueCL>indicated</clueCL> that the epitope recognized by 18C7 was directly <clueType><clueKT>implicated</clueKT></clueType> <linkTheme>in</linkTheme> hormone binding.</clue>
</event>
<sentence id="S14">The lack of <term id="A13" sem="Organic_compound_other">steroid</term> binding of <term id="A12" sem="Protein_molecule"><term id="T44" lex="HBD" sem="Protein_domain_or_region">HBD</term> mutants with the <term id="T45" lex="Thr729-Leu765_sequence" sem="Protein_domain_or_region">Thr729-Leu765 sequence</term> deleted</term> [Jalaguier, Mesnier, Leger and Auzou (1996) J.Steroid Biochem.Mol.Biol.57, 43-50] supports this hypothesis.</sentence>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E40">
<type class="Binding"/>
<theme idref="A13"/>
<theme idref="A12"/>
<clue>The <cluePolarity>lack</cluePolarity> of steroid <clueType>binding</clueType> <linkTheme>of</linkTheme> HBD mutants with the Thr729-Leu765 sequence deleted [Jalaguier, Mesnier, Leger and Auzou (1996) J.Steroid Biochem.Mol.Biol.57, 43-50] <clueKT>supports this <clueCL>hypothesis</clueCL></clueKT>.</clue>
<comment>TPS A12</comment></event>
<sentence id="S15">Because of the similar behaviours of <term id="T46" lex="aldosterone" sem="Lipid">aldosterone</term> and <term id="T47" lex="progesterone" sem="Lipid">progesterone</term>, we conclude that the <term id="A14" sem="Protein_molecule"><term id="T48" lex="N-terminal_Thr729-Leu765_region" sem="Protein_domain_or_region">N-terminal Thr729-Leu765 region</term> of the <term id="T49" lex="HBD" sem="Protein_domain_or_region">HBD</term></term> is similarly involved in the binding of both hormones.</sentence>
<event KT="Other" id="E41">
<type class="Binding"/>
<theme idref="T33"/>
<theme idref="T32"/>
<clue>Because of the similar behaviours of aldosterone and progesterone, we conclude that the N-terminal Thr729-Leu765 region of the HBD is similarly involved in the <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>both hormones</corefTheme>.</clue>
<comment>NO COREFTHEME FOR T32, TPS A14</comment></event>
<event KT="Other" id="E42">
<type class="Binding"/>
<theme idref="T34"/>
<theme idref="T32"/>
<clue>Because of the similar behaviours of aldosterone and progesterone, we conclude that the N-terminal Thr729-Leu765 region of the HBD is similarly involved in the <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>both hormones</corefTheme>.</clue>
<comment>NO COREFTHEME FOR T32</comment></event>
<event KT="Analysis" id="E43">
<type class="Correlation"/>
<theme idref="A14"/>
<theme idref="E41"/>
<clue>Because of the similar behaviours of aldosterone and progesterone, we <clueKT>conclude</clueKT> that the N-terminal Thr729-Leu765 region of the HBD is similarly <clueType>involved</clueType> <linkTheme>in</linkTheme> the binding of both hormones.</clue>
</event>
<event KT="Analysis" id="E44">
<type class="Correlation"/>
<theme idref="A14"/>
<theme idref="E42"/>
<clue>Because of the similar behaviours of aldosterone and progesterone, we <clueKT>conclude</clueKT> that the N-terminal Thr729-Leu765 region of the HBD is similarly <clueType>involved</clueType> <linkTheme>in</linkTheme> the binding of both hormones.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
